Fairvalue-Calculator Fairvalue-Calculator
EN DE

Sino-Agri Leading Biosciences Co (603970) Fair Value & Analysis

Basic Materials · CN · Market cap 2.9B CNY

Price¥10.37
Fair Value¥10.55
Upside+1.7%
Quality91/100
Evidence: High Range ¥5.43 – ¥16.00

Fair value as of: Jun 24, 2026

Analysis

Sino-Agri Leading Biosciences Co (603970) currently trades at ¥10.37, while our model-based Fair Value estimate is ¥10.55 — implying the stock looks roughly 1.7% undervalued today. We read business quality at 91/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company offers insecticides, fungicides, and herbicides products. The company was founded in 2009 and is headquartered in Beijing, China. Sino-Agri Leading Biosciences Co.,Ltd is a subsidiary of China National Agricultural Means of Production Group Corporation.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Sino-Agri Leading Biosciences Co (603970) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥10.55 versus a price of ¥10.37 — about +2% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 603970?
Our 21-model fair value for Sino-Agri Leading Biosciences Co is ¥10.55 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥10.37.
What is the quality score of 603970?
Sino-Agri Leading Biosciences Co has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.